Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Arnold Spek, JanWillem Duitman. Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?. Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013 What have we learned from basic science studies on idiopathic pulmonary fibrosis? Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019 Year: 2019 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences Source: Eur Respir Rev 2015; 24: 420-427 Year: 2015 Idiopathic pulmonary fibrosis trials: recommendations for the jury Source: Eur Respir J 2011; 38: 1002-1004 Year: 2011 Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies Source: Eur Respir J, 52 (3) 1801485; 10.1183/13993003.01485-2018 Year: 2018 Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice Source: International Congress 2015 – Treatment of IPF Year: 2015 Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018 Year: 2019 Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017 Year: 2017 Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017 Year: 2017 Imaging of idiopathic pulmonary fibrosis based on case presentations: guidelines, pitfalls and prevention of misdiagnosis Source: Virtual Congress 2021 – Imaging grand round Year: 2021 Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science Source: Eur Respir J 2016; 47:1615-1617 Year: 2016 Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines Source: Eur Respir Rev 2014; 23:193-214 Year: 2014 The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF Source: Eur Respir J 2015; 46: 883-886 Year: 2015 Idiopathic pulmonary fibrosis: classification, epidemiology, course and prognosis Source: International Congress 2016 – Russia Session Year: 2016